Nicox SA (OTCMKTS:NICXF) Sees Large Drop in Short Interest

Nicox SA (OTCMKTS:NICXF) was the recipient of a large drop in short interest in March. As of March 31st, there was short interest totaling 21 shares, a drop of 95.0% from the March 15th total of 421 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days. Currently, 0.0% of the company’s shares are sold short.

Nicox Price Performance

Shares of NICXF stock remained flat at $0.30 during mid-day trading on Friday. The business has a 50-day moving average of $0.30 and a two-hundred day moving average of $0.30. Nicox has a 12-month low of $0.25 and a 12-month high of $0.30.

Nicox Company Profile

Nicox is a global biopharmaceutical company focused on the research, development and commercialization of innovative treatments for eye diseases. The company’s therapeutic approach centers on nitric oxide–donating compounds and anti-inflammatory agents designed to address glaucoma, ocular surface disorders and allergic eye conditions. With a pipeline spanning pre-clinical to late-stage clinical programs, Nicox aims to bring new modalities to market that target unmet needs in ophthalmology.

The company’s lead commercial product, ZERVIATE® (ciclesonide ophthalmic solution), is indicated for the relief of ocular itching associated with allergic conjunctivitis.